NCT04874142View on ClinicalTrials.gov

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

March 23, 2020

Study Completion Date

March 23, 2020

Conditions
Dyslipidemias
Interventions
DRUG

YYC506-T

single administration

DRUG

YYC506-A

single administration

DRUG

YYC506-T + YYC506-A

concomotant administration

DRUG

YYC506-A + YYC506-T

concomotant administration

Trial Locations (1)

Unknown

ChungBuk National University Hospital, Cheongju-si

All Listed Sponsors
lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT04874142 - Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A | Biotech Hunter | Biotech Hunter